stella
beta
POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors — Stella
Recruiting
Back to Melanoma trials
Trial locations
(2 sites)
Netherlands
NKI-AvL, Amsterdam
University Medical Center Groningen, Groningen
View full record on ClinicalTrials.gov